Back
Nektar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
NKTR
Nektar Therapeutics
Last Price:
$24.18
Seasonality Move:
2.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24 | Buy |
| 20-day SMA: | 21.86 | Buy |
| 50-day SMA: | 14.8 | Buy |
| 200-day SMA: | 14.65 | Buy |
| 8-day EMA: | 20.01 | Buy |
| 20-day EMA: | 12.16 | Buy |
| 50-day EMA: | 5.89 | Buy |
| 200-day EMA: | 1.63 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.61 | Buy |
| Relative Strength Index (14 RSI): | 62.41 | Buy |
| Chaikin Money Flow: | 356028 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.6 - 27.18) | Buy |
| Bollinger Bands (100): | (7.48 - 18.56) | Buy |
Nektar Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 24.14 while NKTR 8-day simple moving average is 24.00, which is a Buy signal.
-
The stock price of NKTR is 24.14 while Nektar Therapeutics 20-day SMA is 21.86, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 14.80 while NKTR share price is 24.14, making it a Buy technically.
-
NKTR stock price is 24.14 and Nektar Therapeutics 200-day simple moving average is 14.65, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
49
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $24.14. The Score for NKTR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
299.5M
Price in USD:
24.14
Share Volume:
958.5K
Nektar Therapeutics 52-Week Range
52-Week High:
37.38
52-Week Low:
6.48
Sell
49
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 24.14 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 24.14 while NKTR 8-day exponential moving average is 20.01, which is a Buy signal.
-
The stock price of NKTR is 24.14 while Nektar Therapeutics 20-day EMA is 12.16, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 5.89 while NKTR share price is 24.14, making it a Buy technically.
-
NKTR stock price is 24.14 and Nektar Therapeutics 200-day simple moving average is 1.63, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 6.61, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 62.41, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (11.6 - 27.18), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is (7.48 - 18.56), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.